Company Analysis

Structure Therapeutics Inc. (GPCR)

Nasdaq: GPCR · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2021
Grade5.8
◀ Past 4.0● Present 7.4▶ Future 5.6
7 est.

Filings

154 filings since 2017 beside 119 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 40 days after the quarter ended. The proxy statement was last filed Apr 23, 2026.

Filings a yearinsider forms included
3978715656
202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Apr 15, 2026.SEC letters: 10 in the last 36 months, the newest Jun 4, 2024.A late-filing notice, Form NT 10-Q, filed Nov 14, 2023.
Insider forms 119

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 9, 2026 10-Q Quarterly report Sep 30, 2026
Nov 9, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 5, 2026 SCHEDULE 13G/A Large holder update, amended
Sep 8, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 6, 2026 SCHEDULE 13G/A Large holder update, amended
Jun 18, 2026 8-K item 5.07 Shareholder vote · Current report Jun 17, 2026
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 1.01, 2.02, 8.01, 9.01 Major agreement signed; Results released; Other event · Current report
May 7, 2026 424B5 Shelf offering
Apr 23, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 23, 2026 DEF 14A Proxy statement Jun 17, 2026
Apr 15, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
Mar 16, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Feb 26, 2026 S-8 Employee stock plan registration
Feb 26, 2026 10-K Annual report Dec 31, 2025
Feb 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 13, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 10, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 5, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 5, 2026 8-K item 1.01 Major agreement signed · Current report Dec 30, 2025
Dec 10, 2025 8-K items 8.01, 9.01 Other event · Current report Dec 9, 2025
Dec 10, 2025 424B5 Shelf offering
Dec 8, 2025 424B5 Shelf offering
Dec 8, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 14, 2025 SCHEDULE 13G Large holder notice
Nov 7, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 7, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 6, 2025 10-Q Quarterly report Sep 30, 2025
Nov 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 18, 2025 SCHEDULE 13G Large holder notice
Aug 14, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 12, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 6, 2025 10-Q Quarterly report Jun 30, 2025
Aug 6, 2025 S-3ASR Shelf registration
40 of 154 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton GPCR · research, not advice